TNFα strongly upregulates VCAM1 expression in static cultures of ECs 1 and we previously confirmed this in HCAECs 2 , defining 5 ng/ml as a maximally effective concentration and 16 hours as an optimal time point (supplementary figures 1, 2). Additionally, TNFα caused a sustained increase in intracellular ROS production, measured in HCAECs 24 hours post treatment (supplementary figures 3A, 3B). While CSE did not increase intracellular ROS production, it significantly enhanced the effect of TNFα alone (Supplementary figure 3C) . Neither treatment caused any increase in apoptosis measured by PARP cleavage, nor was there detectable cytotoxicity (ref 2 and associated supplementary data). Based on these data, 5 ng/ml of TNFα and 10% v/v CSE were used in subsequent experiments Supplementary figure 1. A time course of VCAM1 protein expression in static HCAECs exposed to TNFα over 72 hours. VCAM1 protein expression was quantified using western blot analysis, expressed as mean fold change against control ± S.E. n=3. ** P<0.01 vs control.
Supplementary figure 2. VCAM1 protein expression in static HCAECs exposed to CSE over 72 hours, with TNFα or TNFα + CSE positive controls. VCAM1 protein expression was quantified using western blot analysis, expressed as mean fold change against control ± S.E. n=3.
Supplementary figure 3. Induction of reactive oxygen species in static HCAECs exposed to TNFα and CSE. A, 24hr exposure to TNFα in static HCAECs, ROS expression was quantified using DCF-DA fluorescence, expressed as mean fold change against control ± S.E. n=4. * P<0.05 compared to control; *** P<0.001 compared to control. B, 24hr exposure to CSE in static HCAECs. ROS expression was quantified using DCF-DA fluorescence, expressed as mean fold change against control ± S.E. n=4. C. Induction of reactive oxygen species in static HCAECs exposed to TNFα, CSE and H2O2 and their combination. ROS expression was quantified using DCF-DA fluorescence, expressed as mean fold change against control ± S.E. n=4.* P<0.05 compared to supplemented control; † † P<0.01 vs TNFα alone.
Supplementary figure 4. NFκB (P65) mRNA expression in HCAECs exposed to TNFα, CSE or TNFα and CSE together (T+C) under OSS, LSS or ESS conditions for 72 hours. NFκB p65 mRNA expression was quantified using western blotting analysis, expressed as mean fold change against control ± S.E. n=3. ### P<0.001 vs OSS control; ** P<0.01 vs LSS control; ~~~ P<0.001 vs ESS control; ¥ P<0.05 vs ESST; + P<0.05 vs ESSC.
Supplementary figure 5. PI3 mRNA expression in HCAECs exposed to TNFα, CSE or TNFα and CSE together (T+C) under OSS, LSS or ESS conditions for 72 hours. PI3 mRNA expression was quantified using real-time PCR, expressed as mean fold change against control ± S.E. n=6. ### P<0.001 vs OSS control; *** P<0.001 vs LSS control; ~~~ P<0.001 vs ESS control. n=6
Supplementary figure 6. TNFα mRNA expression in HCAECs exposed to TNFα, CSE or TNFα and CSE together (T+C) under OSS, LSS or ESS conditions for 72 hours. TNFα mRNA expression was quantified using real-time PCR, expressed as mean fold change against control ± S.E. n=6. ### P<0.001 vs OSS control; *** P<0.001 vs LSS control; ∞ P<0.05 vs LSST. n=6
Supplementary figure 7. ATF3 overexpression consistently induced a morphological change in endothelial cells. A, B, C -phase contrast images of HCAEC, A) no virus control; B) βgal virus control (300pfu/cell) C) AdATF3 (300pfu/cell). D, E, F -VE-cadherin (green) and Phalloidin (Red). G, H, IVinculin (green) and Phalloidin (Red). CCGTGGCCACTGCAGGATGTA  62  20  SW180  GAPDH  CGGATTTGGTCGTATTGGGCG  60  30  SW181  GAPDH  GCCTTCTCCATGGTGGTGAAGAC  60  30  SW754  GCLM  GTCCTTGGAGTTGCACAGCTGGA  62  20  SW755  GCLM  GGCATCACACAGCAGGAGGCA  62  20  SW226F  HMOX1  TCAGGCAGAGGGTGATAGAAGAGG  60  30  SW227R  HMOX1  GCCACCAGAAAGCTGAGTGTAAGG  60  30  SW252  ICAM1  CTAAAGGATGGCACTTTCCCACTG  62  20  SW253  ICAM1  CCTTTTTGGGCCTGTTGTAGTCTG  62  20  SW740  IκBα  CGCCCAAGCACCCGGATACA  62  20  SW741  IκBα  AACGTCAGACGCTGGCCTCC  62  20  SW218  KLF2  GTGAGAAGCCCTACCACTGCAACT  60  30  SW219  KLF2  CCGGTTCTCTGGGTCCAATAAATA  60  30  SW369  KLF4  TGGACCCCCTCTCAGCAATG  60  30  SW370  KLF4  CTCTTGGTAATGGAGCGGCG  60  30  SW771 NFκB (RelA) GAAAGGACTGCCGGGATGGCT 62 20 SW772 NFκB (RelA)  GTAGTCCCCACGCTGCTCTTCT  62  20  SW716  NOV  TGGTGCGGCCCTGTGAACAA  62  15  SW717  NOV  AGCGGCCATCACTGCAGACC  62  15  SW496F  NQO1  CTAGTTCCGGCCAGGGTCGC  62  20  SW497R  NQO1  TCCGACTCCACCACCTCCCA  62  20  SW748  OSGIN1  GGGAGCCTGGCACTCCATCG  62  15  SW749  OSGIN1  CCCGGCTGTTGCGAAGACCT  62  15  SW671  PI3  CCTCATCGCTGGGACGCTGG  62  15  SW672  PI3  GGGCAGGAGCCAGGCTTAGT  62  15  SW756  SRXN1  GCCAAGGTGCAGAGCCTCGT  62  15  SW757  SRXN1  GCGGGGATGGTCTCTCGCTG  62  15   SW373   THMB  CAACACACAGGGTGGCTTCG  60  30  SW374  THMB  GGCTGGACAGGCAGTCTGGT  60  30  SW541  TNFα  TCGAACCCCGAGTGACAAGCC  62  20  SW542  TNFα  CTGGTAGGAGACGGCGATGCG  62  20  SW232  VCAM1  GAACCCAAACAAAGGCAGAGTACG  60  30  SW233  VCAM1  TGCTTCTTCCAGCCTGGTTAATTC  60 
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